Filter Results:
(68)
Show Results For
- All HBS Web (499)
- Faculty Publications (186)
Show Results For
- All HBS Web (499)
- Faculty Publications (186)
Page 1 of 68
Results →
Sort by
- 01 Mar 2011
- News
Fixing What Ails the Drug Industry
In 2008, private investors and the National Institutes of Health plowed more than $100 billion into pharmaceutical research. And yet, “We’re not seeing the new diagnostics, treatments, preventative approaches, and cures that we might have... View Details
- 28 Feb 2020
- News
Filling the White Space
companies involved in research into psychedelic compounds for medical use. (Compass has been granted a US patent that covers a method of obtaining psilocybin to treat drug-resistant depression; the treatment is in a phase IIb clinical... View Details
- 01 Sep 2023
- News
Research Brief: Making Way for Moonshots
Josh Krieger (Courtesy subject) Josh Krieger (Courtesy subject) Many innovations in modern medicine have come about due to cutting-edge drugs—advances that required both a scientific leap and a willingness to take risks. And while most pharmaceutical companies would... View Details
Keywords: Jen McFarland Flint
- 01 Jun 2023
- News
Research Brief: The Best Medicine
As it turns out, innovation doesn’t benefit everyone equally, and a new study tries to understand how that plays out in the pharmaceutical R&D process in the United States. “The numbers are striking,” says Associate Professor Joshua... View Details
- 01 Dec 1998
- News
Novartis AG Establishes Global Research Fund
Four HBS professors whose international research efforts range from biotechnology in Taiwan to foreign investments in Costa Rica have been named the first Novartis Faculty Fellows. The two-year fellowships, funded by a $2 million gift... View Details
Keywords: Anne Kavanagh
- 01 Sep 2014
- News
All For One
“collective genius” to describe the kind of leadership she saw at Pixar and assembled her own collective to research it. The team included her then–research associate Emily Truelove and Pixar executive Brandeau, who contributed his own... View Details
- 01 Mar 2007
- News
Daniel Vasella
sales of $37 billion. The company’s aggressive investment in research has made it an industry leader in new drug approvals. And when opportunity knocks, Vasella doesn’t hesitate to broaden Novartis’s business mix through acquisitions. He... View Details
- 20 Mar 2015
- News
Big Pharma Needs to Get Busy in the Lab
- 11 Jan 2017
- News
How do we solve the crisis in cancer communication?
- 04 May 2017
- News
The Error at the Heart of Corporate Leadership
- 05 Jul 2017
- News
Stop the Meeting Madness
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Hi, this is Dan Morrell, host of Skydeck. When Kathy Giusti (MBA 1985) was diagnosed with multiple myeloma in 1996, she was overwhelmed. It was the pre-Internet era, with limited available information, but... View Details
- 31 Jan 2014
- News
Body, Heal Thyself
for the development and exclusive use of the mRNA technology to treat cardiovascular, renal, and metabolic diseases as well as cancer. "It is one of the largest-ever initial payments in a pharmaceutical industry licensing deal that does... View Details
- 13 Jul 2023
- News
The Network Effect
between the two companies. In March 2021, Model was a part of the Agios team that finalized the sale of the biotech’s oncology portfolio to international pharmaceutical company Servier. For Agios, the sale was part of a pivot from cancer... View Details
- 01 Dec 2019
- News
Remix
exercise of getting the mix just right “had almost a pharmaceutical effect on me,” she says. Hip-hop, though, hit a nerve. “I liked the nerdy braininess of digging into the lyrics and wordplay, but it also mashed up the soundtrack of my... View Details
- 01 Feb 1999
- News
Too Much of a Good Thing?
years, sectors as diverse as automobiles, semiconductors, steel, textiles, consumer electronics, tires, and pharmaceuticals have been afflicted by overcapacity and some or all of its unpleasant side effects: loss of jobs, plant closings,... View Details
Keywords: Garry Emmons
- 01 Jun 2023
- News
From Big Pharma to Startup
pharmaceutical giant one day—not creating a company from scratch. But Goble was determined to explore the wide variety of opportunities available to him in his time at HBS, so when he read about a nonprofit life sciences entrepreneurship... View Details
Keywords: April White
- 01 Sep 2007
- News
Alfred D. Chandler Jr. Remembered
Matsushita. That volume was followed in 2005 by Shaping the Industrial Century: The Remarkable Story of the Evolution of the Modern Chemical and Pharmaceutical Industries. “Such science-based industries have had as much impact on this... View Details
- 31 May 2023
- News
Alumni Achievement Awards 2023
A. Schwarzman (MBA 1972) Reshma Kewalramani MD, FASN (GMP 18, 2015) CEO and President, Vertex Pharmaceuticals Big move: “I was almost 12 when we flew from Bombay to the United States. My impressions of the West came from the movie Grease... View Details